Neos Therapeutics
-
Blue Bell’s Neos Therapeutics Competing for Share of $10 Billion ADHD Market
Blue Bell’s Neos Therapeutics is starting to compete for a share of the $10 billion ADHD market with last week’s…
-
Revolutionary ADHD Drug from Blue Bell’s Neos Therapeutics Hits Market
Neos Therapeutics of Blue Bell has a new ADHD drug that became available to prescribe this week, writes John George…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
